658 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Purchased by Signature Estate & Investment Advisors LLC

Signature Estate & Investment Advisors LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 658 shares of the medical equipment provider's stock, valued at approximately $343,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. M.E. Allison & CO. Inc. acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at $449,000. Seilern Investment Management Ltd purchased a new stake in Intuitive Surgical during the 4th quarter worth about $82,517,000. Sycomore Asset Management raised its position in Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock valued at $9,214,000 after purchasing an additional 4,079 shares in the last quarter. Exome Asset Management LLC boosted its stake in shares of Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock valued at $3,649,000 after buying an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. grew its position in shares of Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after buying an additional 525 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares of the company's stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 33,754 shares of company stock worth $17,691,621. Company insiders own 0.70% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. Leerink Partners boosted their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Morgan Stanley raised shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and lifted their price objective for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Stifel Nicolaus increased their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a report on Thursday, December 5th. Raymond James lifted their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. Finally, Piper Sandler reiterated an "overweight" rating and issued a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and a consensus price target of $611.86.

Intuitive Surgical Stock Up 0.7 %

NASDAQ:ISRG traded up $3.43 during trading hours on Monday, reaching $495.27. 2,284,124 shares of the company's stock were exchanged, compared to its average volume of 1,530,088. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The firm has a market capitalization of $176.40 billion, a price-to-earnings ratio of 77.27, a P/E/G ratio of 5.85 and a beta of 1.43. The company has a 50-day moving average of $554.33 and a 200 day moving average of $532.98.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.